학술논문
Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study
Document Type
Article
Author
Jones, Stacie M ; Kim, Edwin H; Nadeau, Kari C; Nowak-Wegrzyn, Anna; Wood, Robert A; Sampson, Hugh A; Scurlock, Amy M; Chinthrajah, Sharon; Wang, Julie; Pesek, Robert D; Sindher, Sayantani B; Kulis, Mike; Johnson, Jacqueline; Spain, Katharine; Babineau, Denise C; Chin, Hyunsook; Laurienzo-Panza, Joy; Yan, Rachel; Larson, David; Qin, Tielin; Whitehouse, Don; Sever, Michelle L; Sanda, Srinath; Plaut, Marshall; Wheatley, Lisa M; Burks, A Wesley
Source
In The Lancet 22-28 January 2022 399(10322):359-371
Subject
Language
ISSN
0140-6736